Sudhir Srivastava Amends 55.8% Stake in SS Innovations

SS Innovations International, Inc. reports amended beneficial ownership by Sudhir Srivastava and Sushruta PVT LTD.

Rhea-AI Filing Summary

SS Innovations International, Inc. reports amended beneficial ownership by Sudhir Srivastava and Sushruta PVT LTD. Sudhir Srivastava beneficially owns 114,490,054 shares, representing 55.8% of the outstanding common stock. Sushruta PVT LTD holds 109,585,767 shares, representing 54.7%. The percentages are calculated using 200,231,535 shares outstanding as of March 9, 2026, per the company’s amended Form 10-K/A. The filing states Dr. Srivastava has a 100% interest in Sushruta PVT LTD and that his reported position includes options to purchase 4,872,287 shares and a direct holding of 32,000 shares.

Insights

Corporate Governance Specialist

Large concentrated ownership is documented by the amended Schedule 13G/A.

The filing shows a controlling stake: 114,490,054 shares (55.8%) attributable to Sudhir Srivastava, including record holdings by Sushruta PVT LTD. The filing clarifies voting and dispositive power is held solely by the reporting persons.

Watch subsequent filings for any changes in ownership or option exercises; timing and cash‑flow treatment for option exercises are not stated in the excerpt.

Securities Compliance Analyst

Amendment confirms record and beneficial ownership details and the joint filing arrangement.

The Schedule 13G/A ties percentages to March 9, 2026 outstanding shares and lists the components of the reported position: record holdings, direct shares, and options. It also states Dr. Srivastava’s 100% interest in Sushruta PVT LTD.

Regulatory watchers should note the ownership thresholds disclosed; future Section 13 filings may reflect changes if options are exercised.

Key Figures

Shares beneficially owned by Sudhir Srivastava: 114,490,054 shares Percent of class (Sudhir Srivastava): 55.8% Shares held by Sushruta PVT LTD: 109,585,767 shares +4 more

7 metrics

Shares beneficially owned by Sudhir Srivastava 114,490,054 shares Amount beneficially owned reported in Schedule 13G/A

Percent of class (Sudhir Srivastava) 55.8% Calculated using 200,231,535 shares outstanding as of March 9, 2026

Shares held by Sushruta PVT LTD 109,585,767 shares Record holdings reported by Sushruta PVT LTD

Percent of class (Sushruta PVT LTD) 54.7% Calculated using 200,231,535 shares outstanding as of March 9, 2026

Shares outstanding used for calculation 200,231,535 shares Outstanding as of March 9, 2026 per amended Form 10-K/A

Options included in reported position 4,872,287 shares Options held by Dr. Srivastava included in beneficial ownership total

Direct shares held by Dr. Srivastava 32,000 shares Directly held common stock reported in disclosure

Key Terms

Schedule 13G/A, beneficially owned, sole dispositive power, shares outstanding as of

4 terms

Schedule 13G/A regulatory

"Amendment No. 3 and header identifying form type"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

beneficially owned regulatory

"Amount beneficially owned: Sudhir Srivastava - 114,490,054"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

sole dispositive power regulatory

"Sole Dispositive Power 114,490,054.00"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

shares outstanding as of market

"200,231,535 shares of common stock outstanding as of March 9, 2026"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does SSII Schedule 13G/A say about Sudhir Srivastava's ownership?

It states Sudhir Srivastava beneficially owns 114,490,054 shares, equal to 55.8% of common stock, based on 200,231,535 shares outstanding as of March 9, 2026. The position includes direct shares, holdings via Sushruta PVT LTD, and options.

How many shares does Sushruta PVT LTD hold in SSII?

The filing shows Sushruta PVT LTD holds 109,585,767 shares, representing 54.7% of the common stock based on 200,231,535 shares outstanding as of March 9, 2026 reported in the amended 10-K/A.

Do the reported holdings include options for SSII?

Yes. The disclosure states the reported position includes options to purchase 4,872,287 shares held by Dr. Srivastava as part of the aggregate ownership reported in the Schedule 13G/A filing.

Does Dr. Srivastava control Sushruta PVT LTD?

The filing explicitly states Dr. Srivastava has a 100% beneficial interest in Sushruta PVT LTD, and the Schedule 13G/A reports shares held of record by that entity as part of his beneficial ownership.

What share count was used to calculate the ownership percentages?

Percentages are calculated using an aggregate of 200,231,535 shares outstanding as of March 9, 2026, as reported in the issuer's Amended Annual Report on Form 10-K/A for the year ended December 31, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/04/2026 - 04:15 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 3)

SS Innovations International, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

05453U203

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 05453U203

1

Names of Reporting Persons

Sudhir Srivastava, M.D.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 114,490,054.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 114,490,054.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

114,490,054.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

55.8 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: Consists of (a) 109,585,767 shares of Common Stock of the Company held by Sushruta PVT LTD; (b) 32,000 shares of Common Stock of the Company held by Dr. Srivastava; and (c) Options held by Dr. Srivastava to purchase 4,872,287 shares of Common Stock of the Company. Dr. Srivastava has a 100% interest in Sushruta PVT LTD. Percentage in Row 11 is calculated based on 200,231,535 shares of common stock outstanding as of March 9, 2026, as reported in the issuer's Amended Annual Report on Form 10-K/A for the year ended December 31, 2025.

SCHEDULE 13G

CUSIP Number(s): 05453U203

1

Names of Reporting Persons

Sushruta PVT LTD

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

BAHAMAS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 109,585,767.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 109,585,767.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

109,585,767.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

54.7 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: Row 5 and Row 7 consists of 109,585,767 shares of Common Stock of the Company held by Sushruta PVT LTD. Percentage in Row 11 is calculated based on 200,231,535 shares of common stock outstanding as of March 9, 2026, as reported in the issuer's Amended Annual Report on Form 10-K/A for the year ended December 31, 2025.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: SS Innovations International, Inc.
(b)	Address of issuer's principal executive offices: 1600 SE 15th Street, #512 Fort Lauderdale, FL 33316
Item 2.
(a)	Name of person filing: (1) Sudhir Srivastava, M.D. (2) Sushruta PVT LTD
(b)	Address or principal business office or, if none, residence: The address for Sudhir Srivastava, M.D., Sushruta PVT LTD and Sudhir Srivastava Innovations PTE LTD is as follows: 1600 SE 15th Street, #512 Fort Lauderdale, FL 33316
(c)	Citizenship: Sudhir Srivastava, M.D. - USA Sushruta PVT LTD - Commonwealth of the Bahamas
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 05453U203
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: (1) Sudhir Srivastava, M.D. - 114,490,054 (2) Sushruta PVT LTD - 109,585,767
(b)	Percent of class: (1) Sudhir Srivastava, M.D. - 55.8% (2) Sushruta PVT LTD - 54.7%. All calculations of percentage ownership herein are based upon an aggregate of 200,231,535 shares of common stock outstanding as of March 9, 2026, as reported in the issuer's Amended Annual Report on Form 10-K/A for the year ended December 31, 2025.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: (1) Sudhir Srivastava, M.D. - 114,490,054 (2) Sushruta PVT LTD - 109,585,767
	(ii) Shared power to vote or to direct the vote: (1) Sudhir Srivastava, M.D. - 0 (2) Sushruta PVT LTD - 0
	(iii) Sole power to dispose or to direct the disposition of: (1) Sudhir Srivastava, M.D. - 114,490,054 (2) Sushruta PVT LTD - 109,585,767
	(iv) Shared power to dispose or to direct the disposition of: (1) Sudhir Srivastava, M.D. - 0 (2) Sushruta PVT LTD - 0
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. The shares of common stock referenced in Item 4, Section (a) above include shares held of record by Sushruta PVT LTD. Dr. Srivastava owns a 100% beneficial interest in Sushruta PVT LTD.
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.	Certifications:
	Not Applicable

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Sudhir Srivastava, M.D.

Signature:	/s/ Sudhir Srivastava
Name/Title:	Sudhir Srivastava, M.D.
Date:	05/04/2026

Sushruta PVT LTD

Signature:	/s/ Sudhir Srivastava
Name/Title:	Sudhir Srivastava, M.D., Authorized Signatory
Date:	05/04/2026

Exhibit Information

JOINT FILING AGREEMENT